Gastric emptying and nutrient absorption of pea protein products differing in heat treatment and texture: a randomized in vivo crossover trial and in vitro digestion study

Julia J.M. Roelofs; Elise J.M. van Eijnatten; Patteela Prathumars; Joris de Jong; Ron Wehrens; Diederik Esser; Anja E.M. Janssen; Paul A.M. Smeets

doi:10.1101/2023.09.13.23295474

Abstract

Background Pea protein is an interesting alternative for animal-based proteins due to its good availability, low cost and relatively balanced amino acid (AA) profile. Its digestibility may be affected by heat treatment and food texture.

Objectives To study in-vivo AA absorption kinetics and gastric behavior of pea protein products differing in heat treatment and texture and compare this with in-vitro digestion.

Design Fourteen males participated in a randomized crossover trial. Iso-caloric and iso-volumetric treatments were a 420-mL heated drink, 420-mL unheated drink and 105-g heated gel (semi-solid) consumed with 315 mL water, all containing 20 g pea protein. Gastric MRI scans were made until 90 minutes post-prandial. Blood samples were collected at baseline and up to five hours. All treatments were tested with an in-vitro digestion model (INFOGEST).

Results Heat treatment did not alter AA absorption kinetics and gastric emptying. Time to maximum peak was delayed for the gel treatment (total AAs: 66.9 versus 48.0 min for both drinks, essential AAs: 75.4 versus 50.0 and 46.6 min for the drinks). For the gel treatment initial emptying was faster due to the rapid passage of water. In-vitro, the degree of hydrolysis was highest for the unheated drink in the gastric phase and for the gel treatment in the intestinal phase.

Conclusion Heat treating pea protein products does not affect digestion. In contrast, texture of pea protein products can be altered to influence the rate of gastric emptying and AA absorption without affecting total AA absorption.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NL9413

Funding Statement

This study was funded by Wageningen University and Research

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for the involvement of human subjects in this study was granted by the Medical Ethical Committee of Wageningen University (Reference number: NL74440.081.20, dated April 13th, 2021).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

Pubmed indexing: Roelofs JJM (julia.roelofs{at}wur.nl), van Eijnatten EJM (elise.vaneijnatten{at}wur.nl), Prathumars P (patteela.prathumars{at}wur.nl), de Jong J (joris.dejong{at}wur.nl), Wehrens R (ron.wehrens{at}wur.nl), Esser D (diederik.esser{at}wur.nl), Janssen AEM (anja.janssen{at}wur.nl), Smeets PAM (paul.smeets{at}wur.nl)
Conflict of interest: none
Source of support: Wageningen University and Research
Ethical statement and registration: "Ethical approval for the involvement of human subjects in this study was granted by the Medical Ethical Committee of Wageningen University (Reference number: NL74440.081.20, dated April 13^th, 2021) and is in accordance with the Helsinki Declaration of 1975 as revised in 2013. This study was registered with the Dutch Trial Registry under number NL9413 (record can be retrieved from the International Clinical Trials Registry Platform at https://trialsearch.who.int/Trial2.aspx?TrialID=NL9413).

Data Availability

All data produced in the present study are available upon reasonable request to the authors

List of abbreviations

AA: Amino Acid
DIAAS: Digestible Indispensable Amino Acid Score
EAA: Essential Amino Acids
SGF: Simulated Gastric Fluid
TAA: Total Amino Acids

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.